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There are complex interconnections of variables such as 
work hours, occupation type, and socioeconomic status 
with physiology that can aﬀ ect the risk of diabetes. Results 
of investigations into associations between long working 
hours and incident type 2 diabetes have been inconsistent. 
In The Lancet Diabetes & Endocrinology, Mika Kivimäki and 
colleagues combine published and unpublished data in 
a meta-analysis (n=222 120) to show that working long 
hours is associated with increased risk of incident diabetes 
in people with low socioeconomic status.1 
Their study design and methods have several 
advantages: large sample size, consistent exposure 
deﬁ nition, control for health behaviours and other 
potential confounders, and analysis to test for bias due 
to the method used to determine diabetes incidence. 
Importantly, the investigators enable clear comparisons 
with previous reports by presenting serially adjusted 
analyses largely replicating previous ﬁ ndings.
However, the investigators’ discussions of residual 
confounders focused primarily on the possibility that 
confounding might explain the higher diabetes risk 
in the low socioeconomic groups; whereas, residual 
confounding by protective factors could lead to an 
underestimation of the eﬀ ect of the exposure in the 
workers in the high socioeconomic status group. 
Workers in this group have additional capital, social, or 
other resources at their disposal that might mitigate 
the eﬀ ects of long working hours. For example, they 
are able to contract out activities such as child care and 
household chores, thereby buying more weekly hours.
Unresolved issues of measurement and residual 
confounding make us guarded about the study’s 
conclusions, especially the assertion that the lack of an 
association in workers in the high socioeconomic status 
group negates the possibility that working long hours 
per se is toxic. In occupational health studies, work hours 
the other hand, if the insulin algorithm was less aggressive 
there would have been less opportunity for glucagon 
action; the value of glucagon is at least partly dependent 
on the insulin algorithm. The true incremental value of 
glucagon will be shown in the unrestricted outpatient 
setting where the control system must cope with a greater 
variety and intensity of challenges to glucose stability. 
A challenge for glucagon use is the availability of a 
stable formulation approved for chronic use in a pump. 
Studies such as Haidar and colleagues’ will encourage 
the pharmaceutical industry to build on progress 
already made towards availability of stable, pumpable 
glucagon.10 The exploration of multiple strategies for 
automated glycaemic control, including those that use 
insulin alone or both insulin and glucagon, will lead 
to more and better options for patients with type 1 
diabetes. Haidar and colleagues should be congratulated 
for taking the fork and advancing our understanding of 
the role of glucagon in this endeavor.
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are an essential component of exposure assessments. 
Fundamentally, the acuity of the work exposure above 
and beyond the duration of habitual paid work hours 
(eg, intensity of physical or mental work, schedule 
ﬂ exibility, and commute burden) is often not measured 
in epidemiological studies.2 Unmeasured diﬀ erences 
in how workers of diﬀ erent socioeconomic groupings 
achieve total weekly hours might aﬀ ect the risk of 
diabetes. Reviews with national samples show that 
workers in the high socioeconomic status group have 
greater schedule control, meaning that they are able to 
spread their hours throughout the week.3 Meanwhile, 
workers in lower socioeconomic status groups might 
achieve the same number of hours by working overtime,3 
a form of long working hours in hourly paid employees 
and with potential health consequences. For example, 
injury rates associated with working overtime (61%) 
are higher than for working 12 h a day (37%) or 60 h a 
week (23%).4 Longer daily schedules or schedules that 
are disruptive, such as early morning arrival, late night 
departure, and non-continuous hours might involve far 
less control in workers in the low socioeconomic status 
group, and involve disruptions of circadian rhythms or 
sleep and other health behaviors.
Kivimaki and colleagues’ ﬁ nding of an association 
only in the low socioeconomic status group suggests 
a possible role of sleep as a mediator; both inadequate 
sleep quality and quantity are strongly predictive of 
incident type 2 diabetes.5 A recent study showed that the 
association between short sleep duration and diabetes 
can be partly attenuated by inclusion of socioeconomic 
status.6 Working more consistent and less disruptive 
hours might explain the lack of associations for the 
individuals in the high socioeconomic status group. 
A related idea is the role of social jet lag—long working 
hours and short sleep during the weekdays combined 
with delayed sleep times on the weekend—that 
disrupts the circadian timing system and adversely 
aﬀ ects metabolism.7 Laboratory studies have identiﬁ ed 
mechanisms by which disruption of the circadian system 
increases the risk of diabetes.8 Night work, a cause of 
circadian disruption, is also associated with higher risks 
of type 2 diabetes. In a prospective 5-year follow-up of 
workers with prediabetes, night workers had a ﬁ ve times 
greater rate of conversion to frank diabetes. Of note, 
stress and an administrative role were associated with a 
greater risk of diabetes, whereas being an oﬃ  ce worker 
and non-smoker, among other factors, were protective 
in the same sample.9 
Kivimäki and colleagues’ elegantly designed study 
provides a solid foundation for both epidemiological 
and intervention work on diabetes risks. The results 
remained robust even after controlling for obesity 
and physical activity, which are often the focus of 
diabetes risk prevention, suggesting that work factors 
aﬀ ecting health behaviours and stress might need to be 
addressed as part of diabetes prevention. 
*Orfeu M Buxton, Cassandra A Okechukwu
Division of Sleep Medicine, Harvard Medical School, Boston, 
MA, USA (OMB); Department of Medicine, Brigham and 
Women’s Hospital, Boston, MA, USA (OMB); Department of 
Social and Behavioral Sciences, Harvard School of Public Health, 
Kresge Building, Boston, MA, USA (OMB, CAO); and Department 
of Biobehavioral Health, Pennsylvania State University, 
219 Biobehavioral Health Bldg, University Park, PA 16802, 
USA (OMB)
Orfeu@PSU.edu
OMB reports grants from Sepracor (now Sunovion) and Cephalon (now Teva); 
personal fees from Takeda Pharmaceuticals North America, Dinsmore, Matsutani 
America, Wake Forest University Medical Center, American Academy of 
Craniofacial Pain, National Institute of  Heart, Lung and Blood Institute, National 
Institute of Diabetes and Digestive and Kidney Diseases, National Postdoctoral 
Association, Oklahoma State University, Oregon Health Sciences University, 
SUNY Downstate Medical Center, American Diabetes Association, and New York 
University outside of the submitted work. CAO declares no competing interests. 
Support was provided by grants from the National Institutes of Health 
(R01HL107240, OMB) and National Institute for Occupational Safety and Health 
and Centers for Disease Control and Prevention (U19OH008861, CAO).
Copyright © Buxton et al. Open Access article distributed under the terms of 
CC BY-NC-SA.
1 Kivimä ki M, Virtanen M, Kawachi I, et al. Long working hours, 
socioeconomic status, and the risk of incident type 2 diabetes: 
a meta-analysis of published and unpublished data from 222 120 
individuals. Lancet Diabetes Endocrinol 2014; published online Sept 25. 
http://dx.doi.org/10.1016/S2213-8587(14)70178-0.
2 Jahoda M. Employment and unemployment: a social-psychological 
analysis. Volume 1: CUP Archive; 1982.
3 Lyness KS, Gornick JC, Stone P, Grotto AR. It’s all about control worker 
control over schedule and hours in cross-national context. Am Sociol Rev 
2012; 77: 1023–49.
4 Dembe AE, Erickson JB, Delbos RG, Banks SM. The impact of overtime and 
long work hours on occupational injuries and illnesses: new evidence from 
the United States. Occup Environ Med 2005; 62: 588–97. 
5 Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep 
and incidence of type 2 diabetes: a systematic review and meta-analysis. 
Diabetes Care 2010; 33: 414–20.
6 Jackson CL, Redline S, Kawachi I, Hu FB. Association between sleep duration 
and diabetes in black and white adults. Diabetes Care 2013; 36: 3557–65.
7 Roenneberg T, Kantermann T, Juda M, Vetter C, Allebrandt KV. Light and 
the human circadian clock. Handb Exp Pharmacol 2013; 217: 311–31.
8 Buxton OM, Cain SW, O’Connor SP, et al. Adverse metabolic consequences 
in humans of prolonged sleep restriction combined with circadian 
disruption. Sci Transl Med 2012; 4: 129ra43.
9 Toshihiro M, Saito K, Takikawa S, Takebe N, Onoda T, Satoh J. Psychosocial 
factors are independent risk factors for the development of type 2 diabetes 
in Japanese workers with impaired fasting glucose and/or impaired glucose 
tolerance. Diabet Med 2008; 25: 1211–17.
